Long-acting oral and parenteral dosing of MK-8591 for HIV treatment or prophylaxis. In Special Issue: Abstracts from the 2016 Conference on Retroviruses and Opportunistic Infections

Journal

Related Articles

See more

Details 詳細情報について

  • CRID
    1370848658892791171
  • Data Source
    • Crossref
Back to top